Keyphrases
Tubulin
66%
Epothilone B
66%
Taxol
50%
Apoptosis
50%
Pharmacokinetics
33%
Protein Expression
33%
Tumor Response
33%
Microtubule Aster
25%
Tumor Samples
16%
Total DNA
16%
GTP Binding
16%
Univariate Analysis
16%
Flow Cytometry
16%
NSCLC Patients
16%
Antitumor Activity
16%
Mitochondrial Membrane Potential
16%
Phosphorylation State
16%
MRNA Expression
16%
Peripheral Blood Mononuclear Cells
16%
Multivariate Analysis
16%
Early Indicators
16%
Phase I Clinical Trial
16%
Microtubules
16%
RNA-protein Complex
16%
Monotherapy
16%
Patient Response
16%
Survivin
16%
Total RNA
16%
Molecular Targets
16%
Toxicity Activity
16%
Poor Response
16%
Binding Region
16%
Clinical Toxicity
16%
Cell Death
16%
Dose Escalation
16%
Biological Markers
16%
Bcl-2 Family
16%
Total Protein
16%
Prognosticator
16%
Cancer mutations
16%
Ovarian Cancer
16%
Multidrug Resistance Protein 1 (MDR1)
16%
Resistant Cancer Cells
16%
β-tubulin Isotypes
16%
Cancer Cell Lines
16%
Drug Transport
16%
RNA-DNA
16%
Stathmin
16%
Microtubule Bundles
16%
Tumor Biopsy
16%
Medicine and Dentistry
Beta Tubulin
100%
Epothilone B
66%
Programmed Cell Death
40%
Paclitaxel
40%
Pharmacokinetics
26%
Neoplasm
26%
Microtubule
26%
Stathmin
13%
Peripheral Blood Mononuclear Cell
13%
Non-Small Cell Lung Cancer
13%
Drug Transport
13%
Optimal Drug Dose
13%
Tumor Biopsy
13%
Ovarian Cancer
13%
Protein Expression
13%
Cell Death
13%
DNA RNA Hybridization
13%
Antineoplastic Activity
13%
Monotherapy
13%
Guanosine Triphosphate
13%
Flow Cytometry
13%
Clinical Trial
13%
Protein P53
13%
Cancer Cell Line
13%
Univariate Analysis
13%
Survivin
13%
Biological Marker
13%
Multivariate Analysis
13%
Mitochondrial Membrane Potential
13%
Multidrug Resistance Protein 1
13%
Cancer Treatment
13%
Multidrug Resistance Associated Protein 2
13%
Biochemistry, Genetics and Molecular Biology
Tubulin
100%
Epothilone
100%
Pharmacokinetics
40%
Bcl-2 Family
20%
Guanosine Triphosphate
20%
Mitochondrial Membrane Potential
20%
Survivin
20%
Flow Cytometry
20%
Clinical Trial
20%
Liquid
20%
P53
20%
Drug Transport
20%
Messenger RNA
20%
DNA RNA Hybridization
20%
Antineoplastic Activity
20%
Optimal Drug Dose
20%
Peripheral Blood Mononuclear Cell
20%
Cancer Cell
20%
Multivariate Analysis
20%
Cell Death
20%
Protein Expression
20%
Multidrug Resistance-Associated Protein 2
20%
Stathmin
20%